DuPont Nutrition divests natural colors business to DDW

USA – DuPont Nutrition & Biosciences has sold its Natural Colors business to DDW, The Color House in line with its strategic focus on ‘high return opportunities’ within company portfolio.

This is part of DuPont’s approach to active portfolio management and capital allocation through evaluation of the business and asset mix in a bid to optimize value creation.

The divestment allows DuPont to actively invest in high growth, high margin areas such as probiotics, plant-based foods or pharma categories.

“The Natural Colors business offers quality natural colors to a global customer base and is an attractive business with two world-class production sites,” said Matthias Heinzel, President, DuPont Nutrition & Biosciences Business.

“However, it is not part of N&B’s strategic focus areas.

“Following a strategic review of the Natural Colors business, we concluded that it would likely deliver greater value as part of a dedicated and leading colors player.”

DuPont said that it was convinced that the natural colors business ‘will thrive’ under DDW’s ownership.

DuPont strengthened its specialty ingredients business when it acquired FMC’s Health and Nutrition business, then a business leader in natural colors.

The business was integrated into DuPont Nutrition & Health, building its position as a leader in sustainable, bio-based food ingredients as well as expanding capabilities in pharma excipients space.

DDW is a global privately held company specializing in natural color solutions for the food and beverage industry.

Headquartered in Kentucky, USA, it supplies caramel color, burnt sugar & natural colorings for bakery, dairy, confectionery, snacks, meat and poultry, cereal and nutraceuticals.

The sale which was completed on June 28, 2019 highlights DuPont’s continuous efforts in driving business growth and maximizing shareholder value.

The company recently combined its nutrition and biosciences divisions to form a US$6.2 billion behemoth named as DuPont Nutrition & Biosciences.

This merger targets to accelerate science-based approach and innovations by providing a unique product portfolio in the global market.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.